Kawasaki disease (KD) is a leading cause of acquired heart disease in children; however, the etiology of this disease is still unclear. Several genome-wide association studies (GWASs) indicated that genetic variations contribute to KD susceptibility and intravenous immunoglobulin (IVIG) responses. Application genetic risk score is another example of pharmacogenomics research for predicting IVIG unresponsiveness. High-throughput DNA sequencing technology has been developed on an unprecedented scale, and more and more genomic information will be available to understand the etiology and treatment of KD.

Original languageEnglish
Title of host publicationKawasaki Disease
PublisherSpringer Nature
Number of pages14
ISBN (Electronic)9789811929441
ISBN (Print)9789811929434
Publication statusPublished - Jan 1 2022


  • Genetics
  • IVIG response
  • Kawasaki disease
  • Susceptibility

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Genetic Study of Kawasaki Disease'. Together they form a unique fingerprint.

Cite this